31 results on '"Pilar, F. U."'
Search Results
2. POS0670 DIAGNOSTIC DELAY IS ASSOCIATED WITH WORSE OUTCOMES IN TERMS OF STRUCTURAL DAMAGE IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS. RESULTS FROM REGISPONSER-AS
3. AB1026 THE TIME OF INTESTINAL BOWEL DISEASE ONSET IS ASSOCIATED WITH THE PHENOTYPE AND DIAGNOSIS IN PATIENTS WITH SPONDYLOARTHRITIS. RESULTS FROM REGISPONSER REGISTRY
4. POS0662 THE SOCIOECONOMIC PROFILE OF PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS IS ASSOCIATED WITH THE SEVERITY OF THE DISEASE AND WITH THE PERMANENT DISABILITY. A CLUSTER ANALYSIS IN A NATIONAL SPANISH REGISTRY
5. POS1038 NAD+ BOOSTERS AS A NOVEL ANTI-INFLAMMATORY TOOL IN RHEUMATOID ARTHRITIS PATIENTS
6. POS0623 INTEGRATED SERUM PROTEOMIC AND METABOLOMIC PROFILES IN SYSTEMIC SCLEROSIS PATIENTS CHARACTERIZE NEW BIOMARKERS ASSOCIATED TO RELEVANT PATHOLOGICAL FEATURES
7. OP0023 UNBIASED HIERARCHICAL CLUSTERING OF CIRCULATING MOLECULAR PROFILES IN RHEUMATOID ARTHRITIS PATIENTS DEFINES PRECISE CV RISK. EFFECTS OF TNFI, IL6RI, AND JAKINIBS
8. AB0980 HOW DO SPONDYLOARTHRITIS START? IDENTIFICATION OF THE FIRST SYMPTOMS ACCORDING TO THE DIAGNOSIS AND HLA-B27. DATA FROM REGISPONSER AND RESPONDIA REGISTRIES
9. AB0798 The presence of heel enthesitis during physical exploration in patients with radiographic axial spondyloarthritis is associated with poorer outcomes after 2 years of follow-up. Data from REGISPONSER-AS
10. POS0058 IDENTIFICATION OF NOVEL BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC AUTOIMMUNE DISEASES THROUGH NEXT GENERATION PROTEOMICS
11. AB1149 EVALUATION OF THE EFFICACY AND SAFETY OF THE SARS-CoV-2 VACCINE IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES TREATED WITH BIOLOGICAL THERAPY.
12. POS0465 UNSUPERVISED CLUSTERING ANALYSIS OF THE SERUM PROTEOME IDENTIFIES SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH DISTINCTIVE DISEASE SEVERITY AND LUPUS NEPHROPATHY
13. POS0488 IDENTIFICATION OF NOVEL DISEASE BIOMARKERS IN SYSTEMIC SCLEROSIS THROUGH HIGH-THROUGHPUT PROTEOMICS
14. POS0946 DISTRIBUTION OF COMORBIDITIES IN SPONDYLOARTHRITIS WITH REGARD TO THE PHENOTYPE AND THE PRESENCE OF PSORIASIS: DATA FROM THE ASAS-COMOSPA STUDY
15. POS0475 INTEGRATIVE CLINICAL, MOLECULAR AND COMPUTATIONAL ANALYSES ALLOW THE IDENTIFICATION OF DISTINCTIVE PHENOTYPES OF RHEUMATOID ARTHRITIS PATIENTS RELATED TO THE CLINICAL INVOLVEMENT AND THE RESPONSE TO TNF INHIBITORS
16. POS0948 HYPERKYPHOSIS IN AXIAL SPONDYLOARTHRITIS: FACTORS THAT PRODUCE ITS APPEARANCE AND EFFECT ON MOBILITY AND FUNCTION
17. SAT0043 SERUM BIOMOLECULES AS POTENTIAL BIOMARKERS OF CLINICAL EFFICACY AND PREDICTORS OF RESPONSE TO BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS PATIENTS
18. SAT0387 ROLE OF HLA-B27 IN THE COMORBIDITIES OBSERVED IN AXIAL SPONDYLOARTHRITIS: DATA FROM COMOSPA
19. AB0338 EVALUATION OF THE ASSOCIATION OF ALLELES OF INTOLERANCE RISK TO METOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS UNDER TREATMENT WITH BIOLOGIC THERAPIES
20. FRI0316 CAN THE MOMENT OF OCCURRENCE OF THE FIRST EPISODE OF UVEITIS PREDICT DIFFERENCES IN THE PROGNOSIS OF SPONDYLOARTHRITIS? DATA FROM THE SPANISH REGISTRY REGISPONSER
21. AB0700 RADIOGRAPHIC PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS UNDER TREATMENT WITH TNF INHIBITORS. DATA FROM REGISPONSERBIO (SPANISH REGISTER OF BIOLOGICAL THERAPY IN SPONDYLOARTHRITIDES)
22. AB0655 IMPACT OF BIOLOGIC THERAPY ON WORK IMPAIRMENT IN REAL LIFE IN AXIAL SPONDYLOARTHRITIS PATIENTS: DATA FROM REGISPONSERBIO
23. SAT0529 CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN A PATIENT GROUP WITH INTERSTITIAL LUNG DISEASE.
24. THE TIME OF INTESTINAL BOWEL DISEASE ONSET IS ASSOCIATED WITH THE PHENOTYPE AND DIAGNOSIS IN PATIENTS WITH SPONDYLOARTHRITIS. RESULTS FROM REGISPONSER REGISTRY.
25. HOW DO SPONDYLOARTHRITIS START? IDENTIFICATION OF THE FIRST SYMPTOMS ACCORDING TO THE DIAGNOSIS AND HLA-B27. DATA FROM REGISPONSER AND RESPONDIA REGISTRIES.
26. INTEGRATED METABOLOMICS AND PROTEOMICS NETWORK ANALYSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS HIGHLIGHTS METABOLIC AND IMMUNITY PATHWAYS ASSOCIATED WITH DISTINCTIVE CLINICAL PROFILES.
27. NAD+ BOOSTERS AS A NOVEL ANTI-INFLAMMATORY TOOL IN RHEUMATOID ARTHRITIS PATIENTS.
28. THE SOCIOECONOMIC PROFILE OF PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS IS ASSOCIATED WITH THE SEVERITY OF THE DISEASE AND WITH THE PERMANENT DISABILITY. A CLUSTER ANALYSIS IN A NATIONAL SPANISH REGISTRY.
29. INTEGRATED SERUM PROTEOMIC AND METABOLOMIC PROFILES IN SYSTEMIC SCLEROSIS PATIENTS CHARACTERIZE NEW BIOMARKERS ASSOCIATED TO RELEVANT PATHOLOGICAL FEATURES.
30. DIAGNOSTIC DELAY IS ASSOCIATED WITH WORSE OUTCOMES IN TERMS OF STRUCTURAL DAMAGE IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS. RESULTS FROM REGISPONSER-AS.
31. UNBIASED HIERARCHICAL CLUSTERING OF CIRCULATING MOLECULAR PROFILES IN RHEUMATOID ARTHRITIS PATIENTS DEFINES PRECISE CV RISK. EFFECTS OF TNFI, IL6RI, AND JAKINIBS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.